Chad Beynon

Stock Analyst at Macquarie

(3.30)
# 1,087
Out of 4,479 analysts
34
Total ratings
53.85%
Success rate
1.75%
Average return

21 Stocks

Hilton Worldwide Holdings
Apr 25, 2024
Maintains: Neutral
Price Target: $192$205
Current: $214.23
Upside: -4.31%
Monarch Casino & Resort
Apr 18, 2024
Maintains: Neutral
Price Target: $75$76
Current: $66.37
Upside: +14.51%
Century Casinos
Apr 10, 2024
Upgrades: Outperform
Price Target: n/a
Current: $2.55
Upside: -
Rush Street Interactive
Mar 7, 2024
Maintains: Outperform
Price Target: $6$8
Current: $9.46
Upside: -15.43%
Light & Wonder
Feb 28, 2024
Maintains: Outperform
Price Target: $100$115
Current: $102.74
Upside: +11.93%
PENN Entertainment
Feb 16, 2024
Maintains: Outperform
Price Target: $35$33
Current: $18.78
Upside: +75.72%
MGM Resorts International
Feb 14, 2024
Reiterates: Outperform
Price Target: $58
Current: $42.86
Upside: +35.32%
Wynn Resorts
Feb 9, 2024
Maintains: Outperform
Price Target: $122$128
Current: $87.67
Upside: +46.00%
Inspired Entertainment
Jan 17, 2024
Downgrades: Neutral
Price Target: $16$10
Current: $9.11
Upside: +9.77%
Full House Resorts
Jan 17, 2024
Downgrades: Neutral
Price Target: $8$6
Current: $4.60
Upside: +30.43%
Red Rock Resorts
Jan 17, 2024
Upgrades: Outperform
Price Target: $51$58
Current: $53.78
Upside: +7.85%
Gambling.com Group
Jun 28, 2023
Initiates: Outperform
Price Target: $13
Current: $7.89
Upside: +64.77%
Cinemark Holdings
May 8, 2023
Maintains: Outperform
Price Target: $18$20
Current: $21.57
Upside: -7.28%
Accel Entertainment
Nov 9, 2022
Maintains: Outperform
Price Target: $14$13
Current: $9.92
Upside: +31.05%
Golden Entertainment
Feb 18, 2022
Maintains: Outperform
Price Target: $64$66
Current: $29.95
Upside: +120.37%
Hyatt Hotels
Jan 18, 2022
Upgrades: Outperform
Price Target: $110
Current: $148.85
Upside: -26.10%
Reading International
Sep 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.43
Upside: -
AMC Entertainment Holdings
Sep 1, 2021
Downgrades: Underperform
Price Target: n/a
Current: $5.04
Upside: -
DraftKings
Mar 10, 2021
Maintains: Outperform
Price Target: n/a
Current: $37.30
Upside: -
Regencell Bioscience Holdings
Dec 6, 2017
Downgrades: Neutral
Price Target: n/a
Current: $3.21
Upside: -
Caesars Entertainment
Apr 20, 2017
Upgrades: Outperform
Price Target: n/a
Current: $37.75
Upside: -